FAS Activation Induces Dephosphorylation of SR Proteins: Dependence on the de novo generation of ceramide and activation of protein phosphatase 1

Charles E. Chalfant, Besim Ogretmen, Sehamuddin Galadari, Bart Jan Kroesen, Benjamin J. Pettus, Yusuf A. Hannun

Research output: Contribution to journalArticle

Abstract

The search for potential targets for ceramide action led to the identification of ceramide-activated protein phosphatases (CAPP). To date, two serine/threonine protein phosphatases, protein phosphatase 2A (PP2A) and protein phosphatase 1 (PP1), have been demonstrated to function as ceramide-activated protein phosphatases. In this study, we show that treatment with either anti-FAS IgM (CH-11) (150 ng/ml) or exogenous D-(e)-C6- ceramide (20 μM) induces the dephosphorylation of the PP1 substrates, serine/arginine-rich (SR) proteins, in Jurkat acute leukemia T-cells. The serine/threonine protein phosphatase inhibitor, calyculin A, but not the PP2A-specific inhibitor, okadaic acid, inhibited both FAS- and ceramide-induced dephosphorylation of SR proteins. Anti-FAS IgM treatment of Jurkat cells led to a significant increase in levels of endogenous ceramide beginning at 2 h with a maximal increase of 10-fold after 7 h. A 2-h pretreatment of Jurkat cells with fumonisin B1 (100 μM), a specific inhibitor of CoA-dependent ceramide synthase, blocked 80% of the ceramide generated and completely inhibited the dephosphorylation of SR proteins in response to anti-FAS IgM. Moreover, pretreatment of Jurkat cells with myriocin, a specific inhibitor of serine-palmitoyl transferase (the first step in de novo synthesis of ceramide), also blocked FAS-induced SR protein dephosphorylation, thus demonstrating a role for de novo ceramide. These results were further supported using A549 lung adenocarcinoma cells treated with D-(e)-C6-ceramide. Dephosphorylation of SR proteins was inhibited by fumonisin B1 and by over-expression of glucosylceramide synthase; again implicating endogenous ceramide generated de novo in regulating the dephosphorylation of SR proteins in response to FAS activation. These results establish a specific intracellular pathway involving both de novo ceramide generation and activation of PP1 to mediate the effects of FAS activation on SR proteins.

Original languageEnglish (US)
Pages (from-to)44848-44855
Number of pages8
JournalJournal of Biological Chemistry
Volume276
Issue number48
DOIs
StatePublished - Nov 30 2001

Fingerprint

Protein Phosphatase 1
Ceramides
Serine
Arginine
Chemical activation
Phosphoprotein Phosphatases
Proteins
Jurkat Cells
Immunoglobulin M
Protein Phosphatase 2
ceramide glucosyltransferase
Cells
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
Okadaic Acid
T-cells
Coenzyme A
Transferases

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

FAS Activation Induces Dephosphorylation of SR Proteins : Dependence on the de novo generation of ceramide and activation of protein phosphatase 1. / Chalfant, Charles E.; Ogretmen, Besim; Galadari, Sehamuddin; Kroesen, Bart Jan; Pettus, Benjamin J.; Hannun, Yusuf A.

In: Journal of Biological Chemistry, Vol. 276, No. 48, 30.11.2001, p. 44848-44855.

Research output: Contribution to journalArticle

Chalfant, Charles E. ; Ogretmen, Besim ; Galadari, Sehamuddin ; Kroesen, Bart Jan ; Pettus, Benjamin J. ; Hannun, Yusuf A. / FAS Activation Induces Dephosphorylation of SR Proteins : Dependence on the de novo generation of ceramide and activation of protein phosphatase 1. In: Journal of Biological Chemistry. 2001 ; Vol. 276, No. 48. pp. 44848-44855.
@article{aff15d16a32b494db42bd5a9453b850f,
title = "FAS Activation Induces Dephosphorylation of SR Proteins: Dependence on the de novo generation of ceramide and activation of protein phosphatase 1",
abstract = "The search for potential targets for ceramide action led to the identification of ceramide-activated protein phosphatases (CAPP). To date, two serine/threonine protein phosphatases, protein phosphatase 2A (PP2A) and protein phosphatase 1 (PP1), have been demonstrated to function as ceramide-activated protein phosphatases. In this study, we show that treatment with either anti-FAS IgM (CH-11) (150 ng/ml) or exogenous D-(e)-C6- ceramide (20 μM) induces the dephosphorylation of the PP1 substrates, serine/arginine-rich (SR) proteins, in Jurkat acute leukemia T-cells. The serine/threonine protein phosphatase inhibitor, calyculin A, but not the PP2A-specific inhibitor, okadaic acid, inhibited both FAS- and ceramide-induced dephosphorylation of SR proteins. Anti-FAS IgM treatment of Jurkat cells led to a significant increase in levels of endogenous ceramide beginning at 2 h with a maximal increase of 10-fold after 7 h. A 2-h pretreatment of Jurkat cells with fumonisin B1 (100 μM), a specific inhibitor of CoA-dependent ceramide synthase, blocked 80{\%} of the ceramide generated and completely inhibited the dephosphorylation of SR proteins in response to anti-FAS IgM. Moreover, pretreatment of Jurkat cells with myriocin, a specific inhibitor of serine-palmitoyl transferase (the first step in de novo synthesis of ceramide), also blocked FAS-induced SR protein dephosphorylation, thus demonstrating a role for de novo ceramide. These results were further supported using A549 lung adenocarcinoma cells treated with D-(e)-C6-ceramide. Dephosphorylation of SR proteins was inhibited by fumonisin B1 and by over-expression of glucosylceramide synthase; again implicating endogenous ceramide generated de novo in regulating the dephosphorylation of SR proteins in response to FAS activation. These results establish a specific intracellular pathway involving both de novo ceramide generation and activation of PP1 to mediate the effects of FAS activation on SR proteins.",
author = "Chalfant, {Charles E.} and Besim Ogretmen and Sehamuddin Galadari and Kroesen, {Bart Jan} and Pettus, {Benjamin J.} and Hannun, {Yusuf A.}",
year = "2001",
month = "11",
day = "30",
doi = "10.1074/jbc.M106291200",
language = "English (US)",
volume = "276",
pages = "44848--44855",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "48",

}

TY - JOUR

T1 - FAS Activation Induces Dephosphorylation of SR Proteins

T2 - Dependence on the de novo generation of ceramide and activation of protein phosphatase 1

AU - Chalfant, Charles E.

AU - Ogretmen, Besim

AU - Galadari, Sehamuddin

AU - Kroesen, Bart Jan

AU - Pettus, Benjamin J.

AU - Hannun, Yusuf A.

PY - 2001/11/30

Y1 - 2001/11/30

N2 - The search for potential targets for ceramide action led to the identification of ceramide-activated protein phosphatases (CAPP). To date, two serine/threonine protein phosphatases, protein phosphatase 2A (PP2A) and protein phosphatase 1 (PP1), have been demonstrated to function as ceramide-activated protein phosphatases. In this study, we show that treatment with either anti-FAS IgM (CH-11) (150 ng/ml) or exogenous D-(e)-C6- ceramide (20 μM) induces the dephosphorylation of the PP1 substrates, serine/arginine-rich (SR) proteins, in Jurkat acute leukemia T-cells. The serine/threonine protein phosphatase inhibitor, calyculin A, but not the PP2A-specific inhibitor, okadaic acid, inhibited both FAS- and ceramide-induced dephosphorylation of SR proteins. Anti-FAS IgM treatment of Jurkat cells led to a significant increase in levels of endogenous ceramide beginning at 2 h with a maximal increase of 10-fold after 7 h. A 2-h pretreatment of Jurkat cells with fumonisin B1 (100 μM), a specific inhibitor of CoA-dependent ceramide synthase, blocked 80% of the ceramide generated and completely inhibited the dephosphorylation of SR proteins in response to anti-FAS IgM. Moreover, pretreatment of Jurkat cells with myriocin, a specific inhibitor of serine-palmitoyl transferase (the first step in de novo synthesis of ceramide), also blocked FAS-induced SR protein dephosphorylation, thus demonstrating a role for de novo ceramide. These results were further supported using A549 lung adenocarcinoma cells treated with D-(e)-C6-ceramide. Dephosphorylation of SR proteins was inhibited by fumonisin B1 and by over-expression of glucosylceramide synthase; again implicating endogenous ceramide generated de novo in regulating the dephosphorylation of SR proteins in response to FAS activation. These results establish a specific intracellular pathway involving both de novo ceramide generation and activation of PP1 to mediate the effects of FAS activation on SR proteins.

AB - The search for potential targets for ceramide action led to the identification of ceramide-activated protein phosphatases (CAPP). To date, two serine/threonine protein phosphatases, protein phosphatase 2A (PP2A) and protein phosphatase 1 (PP1), have been demonstrated to function as ceramide-activated protein phosphatases. In this study, we show that treatment with either anti-FAS IgM (CH-11) (150 ng/ml) or exogenous D-(e)-C6- ceramide (20 μM) induces the dephosphorylation of the PP1 substrates, serine/arginine-rich (SR) proteins, in Jurkat acute leukemia T-cells. The serine/threonine protein phosphatase inhibitor, calyculin A, but not the PP2A-specific inhibitor, okadaic acid, inhibited both FAS- and ceramide-induced dephosphorylation of SR proteins. Anti-FAS IgM treatment of Jurkat cells led to a significant increase in levels of endogenous ceramide beginning at 2 h with a maximal increase of 10-fold after 7 h. A 2-h pretreatment of Jurkat cells with fumonisin B1 (100 μM), a specific inhibitor of CoA-dependent ceramide synthase, blocked 80% of the ceramide generated and completely inhibited the dephosphorylation of SR proteins in response to anti-FAS IgM. Moreover, pretreatment of Jurkat cells with myriocin, a specific inhibitor of serine-palmitoyl transferase (the first step in de novo synthesis of ceramide), also blocked FAS-induced SR protein dephosphorylation, thus demonstrating a role for de novo ceramide. These results were further supported using A549 lung adenocarcinoma cells treated with D-(e)-C6-ceramide. Dephosphorylation of SR proteins was inhibited by fumonisin B1 and by over-expression of glucosylceramide synthase; again implicating endogenous ceramide generated de novo in regulating the dephosphorylation of SR proteins in response to FAS activation. These results establish a specific intracellular pathway involving both de novo ceramide generation and activation of PP1 to mediate the effects of FAS activation on SR proteins.

UR - http://www.scopus.com/inward/record.url?scp=0035977067&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035977067&partnerID=8YFLogxK

U2 - 10.1074/jbc.M106291200

DO - 10.1074/jbc.M106291200

M3 - Article

C2 - 11502750

AN - SCOPUS:0035977067

VL - 276

SP - 44848

EP - 44855

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 48

ER -